BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21856866)

  • 1. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.
    Nahar R; Ramezani-Rad P; Mossner M; Duy C; Cerchietti L; Geng H; Dovat S; Jumaa H; Ye BH; Melnick A; Müschen M
    Blood; 2011 Oct; 118(15):4174-8. PubMed ID: 21856866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
    Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
    Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 is critical for the development of a diverse primary B cell repertoire.
    Duy C; Yu JJ; Nahar R; Swaminathan S; Kweon SM; Polo JM; Valls E; Klemm L; Shojaee S; Cerchietti L; Schuh W; Jäck HM; Hurtz C; Ramezani-Rad P; Herzog S; Jumaa H; Koeffler HP; de Alborán IM; Melnick AM; Ye BH; Müschen M
    J Exp Med; 2010 Jun; 207(6):1209-21. PubMed ID: 20498019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.
    Swaminathan S; Duy C; Müschen M
    Trends Immunol; 2014 Mar; 35(3):131-7. PubMed ID: 24332591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway.
    Hiratsuka T; Takei Y; Ohmori R; Imai Y; Ozeki M; Tamaki K; Haga H; Nakamura T; Tsuruyama T
    Oncogene; 2016 Jun; 35(25):3227-38. PubMed ID: 26522721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.
    Bednarski JJ; Pandey R; Schulte E; White LS; Chen BR; Sandoval GJ; Kohyama M; Haldar M; Nickless A; Trott A; Cheng G; Murphy KM; Bassing CH; Payton JE; Sleckman BP
    J Exp Med; 2016 Feb; 213(2):209-23. PubMed ID: 26834154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
    Geng H; Hurtz C; Lenz KB; Chen Z; Baumjohann D; Thompson S; Goloviznina NA; Chen WY; Huan J; LaTocha D; Ballabio E; Xiao G; Lee JW; Deucher A; Qi Z; Park E; Huang C; Nahar R; Kweon SM; Shojaee S; Chan LN; Yu J; Kornblau SM; Bijl JJ; Ye BH; Ansel KM; Paietta E; Melnick A; Hunger SP; Kurre P; Tyner JW; Loh ML; Roeder RG; Druker BJ; Burger JA; Milne TA; Chang BH; Müschen M
    Cancer Cell; 2015 Mar; 27(3):409-25. PubMed ID: 25759025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling.
    Xu CR; Feeney AJ
    J Immunol; 2009 Feb; 182(3):1362-9. PubMed ID: 19155482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad feedback inhibition of pre-B-cell receptor signaling components.
    Hauser J; Verma-Gaur J; Grundström T
    Mol Immunol; 2013 Jul; 54(3-4):247-53. PubMed ID: 23318223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.
    Erasmus MF; Matlawska-Wasowska K; Kinjyo I; Mahajan A; Winter SS; Xu L; Horowitz M; Lidke DS; Wilson BS
    Sci Signal; 2016 Nov; 9(456):ra116. PubMed ID: 27899526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.
    Müschen M
    Blood; 2015 Jun; 125(24):3688-93. PubMed ID: 25878119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALL.
    Trimarchi T; Aifantis I
    Cancer Cell; 2015 Mar; 27(3):321-3. PubMed ID: 25759017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
    Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
    Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
    Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes.
    Choi SY; Park SK; Yoo HW; Pi JH; Kang CJ
    J Biol Chem; 2016 Jul; 291(29):15008-19. PubMed ID: 27226553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Mechanism of
    Timblin GA; Xie L; Tjian R; Schlissel MS
    Mol Cell Biol; 2017 Jun; 37(12):. PubMed ID: 28373291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.
    Bai L; Chen Y; He Y; Dai X; Lin X; Wen R; Wang D
    Mol Cell Biol; 2007 Sep; 27(17):5957-67. PubMed ID: 17591700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch.
    Mannouji K; Tasaka T; Akiyama T; Irei I; Sano F; Matsuhashi Y; Wada H; Tohyama K; Sugihara T; Sadahira Y
    Pathol Int; 2009 Apr; 59(4):261-4. PubMed ID: 19351371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.
    Sandoval GJ; Graham DB; Bhattacharya D; Sleckman BP; Xavier RJ; Swat W
    J Immunol; 2013 Mar; 190(6):2485-9. PubMed ID: 23420891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.